Repurposed metformin–apigenin combination therapy for metabolic dysfunction-associated steatohepatitis: from integrative multi-omics discovery to in vivo validation

Kanglong Zhang, Yihua Chen, Linwei Ran, Weizhao Tong, Lu Dai, Zhen Yang, Qi Chen, Jie Zheng, Guoxin Hu

Open source

DOI: 10.3389/fphar.2026.1857676
Published: 2026-09-04
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1857676,
  title = {Repurposed metformin–apigenin combination therapy for metabolic dysfunction-associated steatohepatitis: from integrative multi-omics discovery to in vivo validation},
  author = {Kanglong Zhang and Yihua Chen and Linwei Ran and Weizhao Tong and Lu Dai and Zhen Yang and Qi Chen and Jie Zheng and Guoxin Hu},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1857676},
  url = {https://doi.org/10.3389/fphar.2026.1857676}
}

RIS

TY  - JOUR
TI  - Repurposed metformin–apigenin combination therapy for metabolic dysfunction-associated steatohepatitis: from integrative multi-omics discovery to in vivo validation
AU  - Kanglong Zhang
AU  - Yihua Chen
AU  - Linwei Ran
AU  - Weizhao Tong
AU  - Lu Dai
AU  - Zhen Yang
AU  - Qi Chen
AU  - Jie Zheng
AU  - Guoxin Hu
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1857676
UR  - https://doi.org/10.3389/fphar.2026.1857676
ER  -

APA

Zhang, K., Chen, Y., Ran, L., Tong, W., Dai, L., Yang, Z., Chen, Q., Zheng, J., & Hu, G. (2026). Repurposed metformin–apigenin combination therapy for metabolic dysfunction-associated steatohepatitis: from integrative multi-omics discovery to in vivo validation. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1857676

Source records

crossref · retrieved 2026-09-25T17:00:07.879Z